Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation
- PMID: 20072901
- DOI: 10.1007/978-1-60327-360-2_32
Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation
Abstract
In the last two decades, cationic liposomes have been investigated as vehicles for nucleic acids [plasmid DNA (pDNA) and small interfering RNA (siRNA)] delivery in vitro and in vivo. The formation of cationic liposomes-nucleic acids complexes, termed lipoplexes, depends on a number of experimental variables. The quality of the nucleic acid and the cationic liposome as well as the selection of diluents for diluting the concentrated stocks strongly affect the resulting lipoplexes and their efficiency of gene-expression or gene-silencing effect following transfection. In addition, the molar ratio of cationic lipid nitrogen (N) to siRNA or pDNA phosphate (P) (N/P ratio) influences the final characteristics of the lipoplexes, such as size, surface zeta potential, and reproducibility, thereby reflecting their efficiency following transfection. The methods presented in this chapter could be helpful to obtain reliable and reproducible lipoplexes and experimental results.
Similar articles
-
The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.Int J Pharm. 2007 Mar 21;333(1-2):62-9. doi: 10.1016/j.ijpharm.2006.09.057. Epub 2006 Oct 10. Int J Pharm. 2007. PMID: 17097247
-
Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.Biochemistry. 2004 Oct 26;43(42):13348-56. doi: 10.1021/bi048950a. Biochemistry. 2004. PMID: 15491141
-
DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA.J Control Release. 2010 Apr 19;143(2):222-32. doi: 10.1016/j.jconrel.2009.12.001. Epub 2009 Dec 5. J Control Release. 2010. PMID: 19969034
-
Cationic liposomes for gene delivery.Expert Opin Drug Deliv. 2005 Mar;2(2):237-54. doi: 10.1517/17425247.2.2.237. Expert Opin Drug Deliv. 2005. PMID: 16296751 Review.
-
Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers.J Control Release. 2012 Jul 20;161(2):554-65. doi: 10.1016/j.jconrel.2011.11.014. Epub 2011 Nov 23. J Control Release. 2012. PMID: 22123560 Review.
Cited by
-
Lipopeptide delivery of siRNA to the central nervous system.Methods Mol Biol. 2013;948:251-62. doi: 10.1007/978-1-62703-140-0_17. Methods Mol Biol. 2013. PMID: 23070775 Free PMC article.
-
Effective mRNA transfection of tumor cells using cationic triacyl lipid‑based mRNA lipoplexes.Biomed Rep. 2024 Dec 4;22(2):25. doi: 10.3892/br.2024.1903. eCollection 2025 Feb. Biomed Rep. 2024. PMID: 39720303 Free PMC article.
-
siRNA Therapeutics for Protein Misfolding Diseases of the Central Nervous System.Methods Mol Biol. 2021;2282:377-394. doi: 10.1007/978-1-0716-1298-9_20. Methods Mol Biol. 2021. PMID: 33928585
-
Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures.PLoS One. 2010 Jun 14;5(6):e11085. doi: 10.1371/journal.pone.0011085. PLoS One. 2010. PMID: 20559428 Free PMC article.
-
Modulating the tumor microenvironment in a mouse model of colon cancer using a combination of HIF-1α inhibitors and Toll-Like Receptor 7 agonists.Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):5867-5880. doi: 10.1007/s00210-024-03658-8. Epub 2024 Nov 30. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39614894 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous